Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 81803 · Class III · Blood Bank Of Delmarva, Inc
Key facts
| Event ID | 81803 |
|---|---|
| Recall numbers | B-0261-2019 |
| Recalling firm | Blood Bank Of Delmarva, Inc |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, manufactured without the entire quantity of additive solution, was distributed. |
| Initiation date | Nov 12, 2018 |
| Report date | Feb 13, 2019 |
| Termination date | Feb 1, 2019 |
| City | Newark |
| State | DE |
| Country | United States |
| FEI number | 2577603 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: